RNA interference opened new approaches for disease treatment but safe and efficient cell delivery remains a bottleneck. Extracellular vesicles (EVs) are known to naturally shuttle RNA. Due to their potent cell internalization and low‐cost scalability, milk‐derived EVs in particular are considered promising RNA delivery systems. However, low drug loading currently impedes their use. Here, innovative exogenous loading strategies for small interfering RNA (siRNA) are explored and systematically compared regarding encapsulation efficiency, loading capacity, and loading concentration. Firstly, siRNA is pre‐accumulated in liposomes or stabilized calcium phosphate nanoparticles (CaP‐NP). The selected systems, which exhibited neutral or negative zeta potentials, are then applied for EV loading. Secondly, EVs are concentrated and applied to protocols known for liposome loading: dehydration‐rehydration of vesicles, based on freeze‐drying, and mixing by dual asymmetric centrifugation (DAC) after ultracentrifugation. Additionally, DAC after EV ultracentrifugation is combined with CaP‐NP leading to a synergistic loading performance. The balance between energy input for siRNA loading and EV integrity is evaluated by monitoring the EV size, marker proteins, and morphology. For the EV‐based siRNA formulation via DAC plus CaP‐NP, EV properties are sufficiently maintained to protect the siRNA from degradation and deliver cell‐death siRNA dose‐dependently in Caco‐2 cells.
The immediate release of chemotherapeutics at the target site, along with no premature release in circulation is always challenging. The purpose of this study was to develop a stimuli responsive drug delivery system, composed of lipid supported mesoporous silica nanoparticles (MSNPs) for triggered drug release at the target site and simultaneously avoiding the premature release. MSNPs with a higher drug loading capacity and very slow release were designed so as to enhance release by FDA approved US-irradiation. Doxorubicin, as a model drug, and perfluoropentane (PFP) as a US responsive material, were entrapped in the porous structure of MSNPs. Lipid coating enhanced the cellular uptake and in addition provided a gatekeeping effect at the pore opening to reduce premature release. The mechanical and thermal effects of US induced the conversion of liquid PFP to a gaseous form that was able to rupture the lipid layer, resulting in triggered drug release. The prolonged stability profile and non-toxic behavior made them suitable candidate for the delivery of anticancer drugs. This smart system, with the abilities of better cellular uptake and higher cytotoxic effects on US-irradiation, would be a good addition to the applied side of chemotherapeutic advanced drug delivery systems.
31 January 2020 in ACS Applied Materials & Interfaces
In continuation of previous work, we present a new promising DNA carrier: OO4, a highly effective peptide-mimicking lysine-based cationic lipid. The structural characteristics of the polynucleotide carrier system OO4 in mixtures with the commonly used co-lipid DOPE and the saturated phospholipid DPPE have been studied in 2D and 3D model systems in order to understand their influence on the physical-chemical properties. The phase behavior of pure OO4 and its mixtures with DOPE and DPPE were studied at the air-water interface using a Langmuir film balance combined with infrared reflection-absorption spectroscopy (IRRAS). In bulk, the self-assembling structures in presence and absence of DNA were determined by small-angle and wide-angle X-ray scattering (SAXS/WAXS). The amount of adsorbed DNA to cationic lipid bilayers was measured using a quartz crystal microbalance (QCM). The choice of the co-lipid has an enormous influence on the structure and the capability of binding DNA. DOPE promotes the formation of non-lamellar lipoplexes (cubic and hexagonal structures) whereas DPPE promotes the formation of lamellar lipoplexes. The correlation of the observed structures with the transfection efficiency and the serum stability indicates that OO4/DOPE 1:3 lipoplexes with a DNA containing cubic phase encapsulated in multi-lamellar structures seem to be most promising.